Exact Mass: 417.0979

Exact Mass Matches: 417.0979

Found 138 metabolites which its exact mass value is equals to given mass value 417.0979, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Grixazone B

Grixazone B

C18H15N3O7S (417.0631)


A cysteine derivative that is the S-(2-amino-8-carboxy-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.

   

Azelastine Hydrochloride

Azelastine Hydrochloride

C22H25Cl2N3O (417.1375)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D018926 - Anti-Allergic Agents Azelastine hydrochloridem, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine hydrochloride can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2[1][2][3][4].

   

Pelargonidin 3-rhamnoside

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1λ⁴-chromen-1-ylium

C21H21O9+ (417.1186)


Pelargonidin 3-rhamnoside is found in fruits. Pelargonidin 3-rhamnoside is isolated from Ficus sp. and others. Isolated from Ficus species and others. Pelargonidin 3-rhamnoside is found in herbs and spices and fruits.

   

N-Acetyl gemifloxacin

1-cyclopropyl-7-[(4E)-3-acetamido-4-(methoxyimino)pyrrolidin-1-yl]-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

C19H20FN5O5 (417.1448)


N-Acetyl gemifloxacin is a metabolite of gemifloxacin. Gemifloxacin mesylate (trade name Factive, Oscient Pharmaceuticals) is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia. Oscient Pharmaceuticals has licensed the active ingredient from LG Life Sciences of Korea. (Wikipedia)

   

3'-Amino-3'-deoxythimidine glucuronide

(2S,3S,4S,5R)-4-{[3-amino-5-(4-hydroxy-5-methyl-2-oxo-1,2-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}-3,5,6-trihydroxyoxane-2-carboxylic acid

C16H23N3O10 (417.1383)


3-Amino-3-deoxythimidine glucuronide is a metabolite of zidovudine. Zidovudine or azidothymidine (AZT) (also called ZDV) is a nucleoside analog reverse-transcriptase inhibitor (NRTI), a type of antiretroviral drug used for the successful treatment of HIV/AIDS infectiousness. It is a therapeutic analog of thymidine. AZT is the first U.S. government-approved treatment for HIV therapy, prescribed under the names Retrovir and Retrovis. (Wikipedia)

   

Ochratoxin A methyl ester

5-Chloro-8-hydroxy-N-(1-methoxy-1-oxo-3-phenylpropan-2-yl)-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboximidate

C21H20ClNO6 (417.0979)


   

Pexidartinib

5-({5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine

C20H15ClF3N5 (417.0968)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Temafloxacin

1-(2,4-Difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-7-(3-methyl-1-piperazinyl)quinoline-3-carboxylic acid, hydrochloride

C21H18F3N3O3 (417.13)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

Triazolo-benzophenone

2-Amino-N-({4-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-methyl-4H-1,2,4-triazol-3-yl}methyl)ethanimidate

C19H17Cl2N5O2 (417.0759)


   

Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(Cl)c1O

4-[2-(2-Amino-3-chloro-4-hydroxy-5-methylphenyl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulphonamide

C18H16ClN5O3S (417.0662)


   
   

Gesnerin

5- (beta-D-Glucopyranosyloxy) -7-hydroxy-2- (4-hydroxyphenyl) -1-benzopyrylium

C21H21O9 (417.1186)


   

Apigeninidin 7-glucoside

5,7,4-Trihydroxyflavylium 7-glucoside

C21H21O9 (417.1186)


   
   

3-O-beta-D-glucopyranosylfagomine

(-)-3-O-beta-D-Glucopyranosylfagomine

C21H23NO8 (417.1424)


   

Pelargonidin 3-rhamnoside

3,5,7,4-Tetrahydroxyflavylium 3-rhamnoside

C21H21O9 (417.1186)


   
   
   
   
   
   

(5S,8S,9R)-8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexenyl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione|8-O-demethylpseurotin A|pseurotin F2

(5S,8S,9R)-8-benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexenyl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione|8-O-demethylpseurotin A|pseurotin F2

C21H23NO8 (417.1424)


   
   

Sorbicillacton A|sorbicillactone A

Sorbicillacton A|sorbicillactone A

C21H23NO8 (417.1424)


   

2-hydroxy-7-(beta-D-glucopyranosyloxymethyl)-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione

2-hydroxy-7-(beta-D-glucopyranosyloxymethyl)-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione

C17H23NO9S (417.1093)


   
   
   

5-HYDROXYNEOLAMELLARIN B

5-HYDROXYNEOLAMELLARIN B

C24H19NO6 (417.1212)


   

2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester

2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester

C21H20ClNO6 (417.0979)


   
   

Coptisine sulfate

Coptisine (Sulfate)

C19H15NO8S (417.0518)


Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1]. Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1].

   

N-ethyl-2-pyrrolidinone substituted flavan-3-ols (three hydroxy groups on B-ring)

N-ethyl-2-pyrrolidinone substituted flavan-3-ols (three hydroxy groups on B-ring)

C21H23NO8 (417.1424)


   

C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

NCGC00380250-01_C21H23NO8_(2E)-4-({(3S,3aR,4E,7aS)-7-Hydroxy-4-[(2E,4E)-1-hydroxy-2,4-hexadien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydro-1-benzofuran-3-yl}amino)-4-oxo-2-butenoic acid

C21H23NO8 (417.1424)


   

C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

NCGC00381007-01_C21H23NO8_(5S,8S,9R)-8-Benzoyl-2-[(1S,2S,3Z)-1,2-dihydroxy-3-hexen-1-yl]-8,9-dihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione

C21H23NO8 (417.1424)


   
   

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate])

Mefenamic acid Metabolite (b-D-Glucopyranuronic acid, 1-[2-[(2,3-dimethylphenyl)amino]benzoate])

C21H23NO8 (417.1424)


   
   

Asn-TyrMe-OH

(S)-2-(3-(2-amino-2-oxoethoxy)-4-nitrobenzamido)-4-(4-methoxyphenyl)butanoic acid

C19H19N3O8 (417.1172)


   

Tyr-Asn-OH

(S)-5-amino-2-(3-(4-hydroxyphenethoxy)-4-nitrobenzamido)-5-oxopentanoic acid

C19H19N3O8 (417.1172)


   
   
   

dichlorodihydroxybis(isopropylamine)platinum

dichlorodihydroxybis(isopropylamine)platinum

C6H20Cl2N2O2Pt (417.055)


   

N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE

N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE

C20H17ClFN3O4 (417.0892)


   

Bisoxatin acetate

[4-[2-(4-acetyloxyphenyl)-3-oxo-4H-1,4-benzoxazin-2-yl]phenyl] acetate

C24H19NO6 (417.1212)


   

5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)

5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)

C19H15NO8S (417.0518)


   

trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide

trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide

C16H24IN3O2 (417.0913)


   

azaspirium chloride

azaspirium chloride

C22H24ClNO5 (417.1343)


   

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside

2-Azidoethyl 2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranoside

C16H23N3O10 (417.1383)


   

(-)-Bicuculline methochloride

(-)-Bicuculline methochloride

C21H20ClNO6 (417.0979)


   

Bretazenil

Bretazenil

C19H20BrN3O3 (417.0688)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

Pyroxamine maleate [USAN]

Pyroxamine maleate [USAN]

C22H24ClNO5 (417.1343)


   

Sulfatolamide

4-(aminomethyl)benzenesulfonamide,(4-aminophenyl)sulfonylthiourea

C14H19N5O4S3 (417.0599)


G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AE - Sulfonamides C254 - Anti-Infective Agent > C2166 - Combination Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

3,3-dimethyl-13-(4-nitrophenyl)-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione

3,3-dimethyl-13-(4-nitrophenyl)-4,13-dihydro-2H-indazolo[1,2-b]phthalazine-1,6,11-trione

C23H19N3O5 (417.1325)


   

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

C27H19N3O2 (417.1477)


   

Duloxetine Impurity A

Duloxetine Impurity A

C25H23NO3S (417.1399)


   

4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]

4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]

C16H19NO10S (417.073)


   

Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized

Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized

C12H25MoN5O5------ (417.091)


   

3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile

3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile

C19H17Cl2N5S (417.0582)


   

nile blue perchlorate

nile blue perchlorate

C20H20ClN3O5 (417.1091)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes

   

Mono-POC Methyl Tenofovir (Mixture of DiastereoMers)

Mono-POC Methyl Tenofovir (Mixture of DiastereoMers)

C15H24N5O7P (417.1413)


   

Xaliproden hydrochloride

Xaliproden hydrochloride

C24H23ClF3N (417.1471)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent Xaliproden hydrochloride (SR57746A) is a potent, selective and orally active agonist of 5-HT1A receptor, shows a high affinity for 5-HT1A specific binding sites in the rat hippocampus (IC50=3 nM). Xaliproden hydrochloride is also a selective antagonist of dopamine D2 receptor, has moderate affinity (IC50=0.1-1 μM). Xaliproden hydrochloride exhibits anti-depression and anti-anxiety effects, and it may possess therapeutic potential for the research of neurodegenerative diseases[1][2][3].

   
   
   

3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile

3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile

C19H17Cl2N5S (417.0582)


   
   

2-(5-Methoxy-1H-indol-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine

2-(5-Methoxy-1H-indol-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine

C23H19N3O3S (417.1147)


   

5-O-(N-(Alanyl)sulfamoyl)adenosine

5-O-(N-(Alanyl)sulfamoyl)adenosine

C13H19N7O7S (417.1067)


   

4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide

4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide

C18H16ClN5O3S (417.0662)


   

Triazolo-benzophenone

Triazolo-benzophenone

C19H17Cl2N5O2 (417.0759)


   

14-norpseurotin A

14-norpseurotin A

C21H23NO8 (417.1424)


An alkaloid that is the 14-nor derivative of pseurotin A. Isolated from Aspergillus sydowii, it exhibits antibacterial, antileishmanial and anticancer activities.

   

(R)-temafloxacin

(R)-temafloxacin

C21H18F3N3O3 (417.13)


   

(S)-temafloxacin

(S)-temafloxacin

C21H18F3N3O3 (417.13)


   

3-(4-morpholinyl)-4-(2-pyridinyl)-N-[3-(trifluoromethyl)phenyl]-1-pyrazolecarboxamide

3-(4-morpholinyl)-4-(2-pyridinyl)-N-[3-(trifluoromethyl)phenyl]-1-pyrazolecarboxamide

C20H18F3N5O2 (417.1413)


   

N-(3-Chloro-4-Methoxy-Phenyl)-N-(3,4,5-Trimethoxyphenyl)-1,3,5-Triazine-2,4-Diamine

N-(3-Chloro-4-Methoxy-Phenyl)-N-(3,4,5-Trimethoxyphenyl)-1,3,5-Triazine-2,4-Diamine

C19H20ClN5O4 (417.1204)


   

N6-Isopentenyl-Adenosine-5-Monophosphate

N6-Isopentenyl-Adenosine-5-Monophosphate

C15H24N5O7P (417.1413)


   

Pexidartinib

Pexidartinib

C20H15ClF3N5 (417.0968)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

2-phenyl-N-(6-(piperazin-1-yl)pyridin-3-yl)-4-(trifluoromethyl)oxazole-5-carboxamide

2-phenyl-N-(6-(piperazin-1-yl)pyridin-3-yl)-4-(trifluoromethyl)oxazole-5-carboxamide

C20H18F3N5O2 (417.1413)


   

6-[3-Hydroxy-2-(3,5,7-trioxononanoyl)phenyl]-3,5-dioxohexanoate

6-[3-Hydroxy-2-(3,5,7-trioxononanoyl)phenyl]-3,5-dioxohexanoate

C21H21O9- (417.1186)


   

HDM2BOA-glucoside

HDM2BOA-glucoside

C17H23NO11 (417.1271)


   

kaempferol 3-O-beta-D-xyloside(1-)

kaempferol 3-O-beta-D-xyloside(1-)

C20H17O10- (417.0822)


An organic anion obtained by selective deprotonation of the 7-hydroxy group of kaempferol 3-O-beta-D-xyloside; major species at pH 7.3.

   

1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose

1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose

C12H19NO13S (417.0577)


   

(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide

(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide

C19H15NO10 (417.0696)


   

3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile

3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile

C23H15NO7 (417.0848)


   

N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide

N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide

C19H14F3N5OS (417.0871)


   

1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine

1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine

C17H19N7O2S2 (417.1042)


   

N-butyl-N-[5-(3,4,5-trimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

N-butyl-N-[5-(3,4,5-trimethoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

C20H23N3O5S (417.1358)


   

Ethyl 5-acetyl-2-({[2-(2-ethoxybenzylidene)hydrazino]carbonyl}amino)-4-methylthiophene-3-carboxylate

Ethyl 5-acetyl-2-({[2-(2-ethoxybenzylidene)hydrazino]carbonyl}amino)-4-methylthiophene-3-carboxylate

C20H23N3O5S (417.1358)


   

2-(2-furyl)-N-[(4-keto-3,5-dimethoxy-cyclohexa-2,5-dien-1-ylidene)methyl]cinchoninohydrazide

2-(2-furyl)-N-[(4-keto-3,5-dimethoxy-cyclohexa-2,5-dien-1-ylidene)methyl]cinchoninohydrazide

C23H19N3O5 (417.1325)


   

N,N-diethyl-5-nitro-2-[(2-oxo-3-indolyl)hydrazo]benzenesulfonamide

N,N-diethyl-5-nitro-2-[(2-oxo-3-indolyl)hydrazo]benzenesulfonamide

C18H19N5O5S (417.1107)


   

N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide

N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide

C19H19N3O4S2 (417.0817)


   

Dimethyl 2-[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylfuran-3-carbonyl]amino]pentanedioate

Dimethyl 2-[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylfuran-3-carbonyl]amino]pentanedioate

C21H23NO8 (417.1424)


   

3-(2-hydroxyphenyl)-N-{[5-(8-quinolinylthio)-2-furyl]methylene}propanohydrazide

3-(2-hydroxyphenyl)-N-{[5-(8-quinolinylthio)-2-furyl]methylene}propanohydrazide

C23H19N3O3S (417.1147)


   

N-[(1S)-1-(1H-benzimidazol-2-yl)-3-(methylthio)propyl]-2-(4-chlorophenoxy)-2-methylpropanamide

N-[(1S)-1-(1H-benzimidazol-2-yl)-3-(methylthio)propyl]-2-(4-chlorophenoxy)-2-methylpropanamide

C21H24ClN3O2S (417.1278)


   

N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamide

N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamide

C21H24ClN3O4 (417.1455)


   

Pelargonidin 3-rhamnoside

Pelargonidin 3-rhamnoside

C21H21O9+ (417.1186)


   

2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide

2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide

C21H24ClN3O2S (417.1278)


   

4-(4-Morpholinyl)-3-nitrobenzoic acid 2-[3-(cyanomethyl)-4-methyl-5-thiazol-3-iumyl]ethyl ester

4-(4-Morpholinyl)-3-nitrobenzoic acid 2-[3-(cyanomethyl)-4-methyl-5-thiazol-3-iumyl]ethyl ester

C19H21N4O5S+ (417.1233)


   

N-[4-(4-chlorophenyl)-2-thiazolyl]-N-[3-(diethylamino)propyl]-2-furancarboxamide

N-[4-(4-chlorophenyl)-2-thiazolyl]-N-[3-(diethylamino)propyl]-2-furancarboxamide

C21H24ClN3O2S (417.1278)


   

(1R,9S,10S,11S)-N-benzyl-10-(hydroxymethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1R,9S,10S,11S)-N-benzyl-10-(hydroxymethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C20H23N3O5S (417.1358)


   

(1S,9R,10R,11R)-N-benzyl-10-(hydroxymethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

(1S,9R,10R,11R)-N-benzyl-10-(hydroxymethyl)-12-methylsulfonyl-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C20H23N3O5S (417.1358)


   

ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)

ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)

C6H20Cl2N2O2Pt (417.055)


   

Trovafloxacin(1+)

Trovafloxacin(1+)

C20H16F3N4O3+ (417.1174)


An organic cation that is the conjugate acid of trovafloxacin, obtained by protonation of the primary amino group.

   

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

C16H24N3O8P-2 (417.1301)


   

deoxynivalenol 10-S-cysteine

deoxynivalenol 10-S-cysteine

C18H27NO8S (417.1457)


   

3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

C20H16FNO4S2 (417.0505)


   

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-[2-(2-hydroxyethoxy)ethyl]pyrrolidine-2,3-dione

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-[2-(2-hydroxyethoxy)ethyl]pyrrolidine-2,3-dione

C21H23NO8 (417.1424)


   
   

3-Methoxy-2,6-dimethyl-(6R)-((2R)-2-methylbutyryloxy)-5-(4-nitrobenzoyloxy)-2,4-cyclohexadien-1-one

3-Methoxy-2,6-dimethyl-(6R)-((2R)-2-methylbutyryloxy)-5-(4-nitrobenzoyloxy)-2,4-cyclohexadien-1-one

C21H23NO8 (417.1424)


   

temafloxacin

temafloxacin

C21H18F3N3O3 (417.13)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

N-Acetyl gemifloxacin

N-Acetyl gemifloxacin

C19H20FN5O5 (417.1448)


   

3-Amino-3-deoxythimidine glucuronide

3-Amino-3-deoxythimidine glucuronide

C16H23N3O10 (417.1383)


   

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)

C16H24N3O8P (417.1301)


Dianion of N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.

   

2-[(3s,3ar)-7-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile

2-[(3s,3ar)-7-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile

C21H20ClNO6 (417.0979)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(2r)-2,3-dihydroxy-8,8-dimethyl-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h-1,4-benzothiazin-5-one

(2r)-2,3-dihydroxy-8,8-dimethyl-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h-1,4-benzothiazin-5-one

C17H23NO9S (417.1093)


   

8-amino-9-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxophenoxazine-2-carboxylic acid

8-amino-9-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxophenoxazine-2-carboxylic acid

C18H15N3O7S (417.0631)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(2e)-3-{[(3s,3ar,4z,7as)-7-hydroxy-4-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

(2e)-3-{[(3s,3ar,4z,7as)-7-hydroxy-4-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H23NO8 (417.1424)


   

2-{4-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile

2-{4-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile

C21H20ClNO6 (417.0979)


   

3-{[7-hydroxy-4-(1-hydroxyhexa-2,4-dien-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

3-{[7-hydroxy-4-(1-hydroxyhexa-2,4-dien-1-ylidene)-3,6,7a-trimethyl-2,5-dioxo-3ah-1-benzofuran-3-yl]-c-hydroxycarbonimidoyl}prop-2-enoic acid

C21H23NO8 (417.1424)


   

2-[(3s,3ar)-4-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile

2-[(3s,3ar)-4-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile

C21H20ClNO6 (417.0979)


   

2-{7-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile

2-{7-chloro-3a-[(3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl)oxy]-3-hydroxy-3h-cyclopenta[a]inden-5-yl}acetonitrile

C21H20ClNO6 (417.0979)


   

8-benzoyl-2-(1,2-dihydroxypent-3-en-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxypent-3-en-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,8,9-trihydroxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C21H21O9]+ (417.1186)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s)-1,2-dihydroxypent-3-en-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

2,3-dihydroxy-8,8-dimethyl-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h-1,4-benzothiazin-5-one

2,3-dihydroxy-8,8-dimethyl-7-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h-1,4-benzothiazin-5-one

C17H23NO9S (417.1093)


   

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

8-benzoyl-2-(1,2-dihydroxyhex-3-en-1-yl)-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8ar)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8ar)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)


   

n-[(2r,3r,9e)-10-chloro-2-(6,6-dichlorohex-5-en-3-yn-1-yl)-1-methoxy-1-oxodec-9-en-7-yn-3-yl]ethanimidic acid

n-[(2r,3r,9e)-10-chloro-2-(6,6-dichlorohex-5-en-3-yn-1-yl)-1-methoxy-1-oxodec-9-en-7-yn-3-yl]ethanimidic acid

C19H22Cl3NO3 (417.0665)


   

8-amino-9-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-oxophenoxazine-2-carboxylic acid

8-amino-9-{[(2r)-2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl]sulfanyl}-7-oxophenoxazine-2-carboxylic acid

C18H15N3O7S (417.0631)


   

3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)


   

2,15'-dihydroxy-16',16'-dimethyl-14'-oxa-2',10'-diazaspiro[indole-3,13'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1',3',5',7'-tetraene-9',17'-dione

2,15'-dihydroxy-16',16'-dimethyl-14'-oxa-2',10'-diazaspiro[indole-3,13'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1',3',5',7'-tetraene-9',17'-dione

C23H19N3O5 (417.1325)


   

(3s,11'r,15'r)-2,15'-dihydroxy-16',16'-dimethyl-14'-oxa-2',10'-diazaspiro[indole-3,13'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1',3',5',7'-tetraene-9',17'-dione

(3s,11'r,15'r)-2,15'-dihydroxy-16',16'-dimethyl-14'-oxa-2',10'-diazaspiro[indole-3,13'-tetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadecane]-1',3',5',7'-tetraene-9',17'-dione

C23H19N3O5 (417.1325)


   

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

(5r,8s,9r)-8-benzoyl-2-[(1s,2s,3z)-1,2-dihydroxyhex-3-en-1-yl]-6,9-dihydroxy-8-methoxy-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C21H23NO8 (417.1424)


   

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)